- Title
- Assessing AML-based risk criteria in patients with accelerated/blast-phase MPN treated with less-intensive therapy
- Creators
- Reid Shaw - University of ChicagoJames J Yoon - Memorial Sloan Kettering Cancer CenterHannah Johnston - University of ChicagoMarta B Davidson - Princess Margaret Cancer CentreAlexa J Siddon - Yale UniversityRory M Shallis - Yale UniversityEvan Chris Chen - Dana-Farber Cancer InstituteMadelyn Burkart - Atrium Health Wake Forest BaptistTimothy S Oh - Northwestern UniversitySunil Girish Iyer - Columbia University Irving Medical CenterEllen Madarang - University of MiamiChandrasekar Muthiah - Medical College of WisconsinJoshua Kassner - Cornell UniversityRaajit K Rampal - Memorial Sloan Kettering Cancer CenterGuru Subramanian Guru Murthy - Medical College of WisconsinTerrence J Bradley - University of MiamiYasmin Abaza - Northwestern UniversityJacqueline S Garcia - Dana-Farber Cancer InstituteVikas Gupta - Princess Margaret Cancer CentreKristen M Pettit - University of Michigan–Ann ArborOlatoyosi Odenike - University of ChicagoAnand A Patel - University of Chicago
- Publication Details
- Blood advances
- Academic Unit
- Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
- Language
- English
- Resource Type
- Journal article
- PMID
- 39969200
- Record Identifier
- 991032562823502976
Journal article
Assessing AML-based risk criteria in patients with accelerated/blast-phase MPN treated with less-intensive therapy
Blood advances
2025-02-19
PMID: 39969200
Metrics
4 Record Views